Seaport Therapeutics, Inc. Common Stock

NASDAQ:SPTX

Biotechnology

Healthcare
$18.31 +0.58%

+$0.10 today

Market cap
$980.14M
Beta
0.00
52W Low $14.85High $23.00

Volume 0.68M

Average 0.41M

SPTX Operating Cash Flow

Cash generated by the company's core business operations during the period.

No reported Operating Cash Flow figures are available to summarize.

Operating Cash Flow history

Currency unavailable · from the cash flow

No Operating Cash Flow data reported for this period type.

Operating Cash Flow vs competitors

How SPTX compares with its peers on the latest reported figures

SPTX Competitors
Operating Cash Flow for SPTX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
NMRANeumora Therapeutics, Inc. Common StockLTM Mar 2026$193.4M USD-3.0%+21.6%—
MPLTMapLight Therapeutics, Inc.LTM Mar 2026$163.77M USD+94.0%+73.2%—
VNDAVanda Pharmaceuticals Inc.LTM Mar 2026$126.51M USD+124.0%—58.1%
RAPPRapport Therapeutics, Inc. Common StockLTM Mar 2026$80.3M USD+19.0%+199.9%401.5%
CTNMContineum Therapeutics, Inc. Class A Common StockLTM Mar 2026$57.17M USD+46.0%+40.1%—
LBRXLB Pharmaceuticals Inc Common StockLTM Mar 2026$51.63M USD—+134.6%—
GHRSGH Research PLCLTM Mar 2026$46.33M USD+12.3%+18.5%—
SPTXSeaport Therapeutics, Inc. Common Stock—— ———
Peer median (excluding SPTX) —+32.5%+56.7%229.8%

Competitors are the stored peer set for SPTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Seaport Therapeutics, Inc. Common Stock

NASDAQ:SPTX

Intrinsic Alpha fair value

Locked

Current Price

$18.31

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.